Actinogen Medical Doses First Participant in Alzheimer's Disease Trial in US; Shares Rise Nearly 7%

MT Newswires2024/12/09 12:10

This Biotech Stock Raised $11M in a Risk-off Environment. Its Alzheimer's Drug Could Change the Game

The Market Herald2024/11/25 00:00

Actinogen Receives $9M R&D Tax Rebate to Fund Alzheimer's Trial

The Market Herald2024/11/12 10:41

Actinogen Medical Ltd: Actinogenは900万ドルの研究開発税制上の優遇措置を受けます

ASX2024/11/12 06:48

Actinogen Medical Ltd: 株主への年次報告書

ASX2024/10/11 07:59

Actinogen Medical Completes AU$8.1 Million Placement, Launches AU$3 Million Share Purchase Plan; Shares Fall 9%

MT Newswires2024/09/18 14:06